Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.5000
+0.0298 (6.34%)
Oct 15, 2026, 4:00 PM EDT - Market closed
Outlook Therapeutics Stock Forecast
OTLK's stock price has decreased by -65.28% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 analysts polled by S&P Global, Outlook Therapeutics stock has a consensus rating of "Buy" and an average price target of $5.03. The average 1-year stock price forecast is 906.00% higher than the current stock price, while the lowest is $1.60 (+220.00%) and the highest is $10.5 (+2,000.00%).
Price Target: $5.03 (+906.00%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Sep 10, 2026.
Analyst Ratings
The average analyst rating for Outlook Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant | Ascendiant | Buy Maintains $10 → $11 | Buy | Maintains | $10 → $11 | +2,000.00% | Sep 10, 2026 |
| BTIG | BTIG | Buy Reiterates $4 | Buy | Reiterates | $4 | +700.00% | Aug 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $1.6 | Hold | Reiterates | $1.6 | +220.00% | Jul 27, 2026 |
Financial Forecast
Revenue This Year
682.67K
from 1.41M
Decreased by -51.70%
Revenue Next Year
44.07M
from 682.67K
Increased by 6,355.64%
EPS This Year
-0.44
from -1.89
EPS Next Year
-0.12
from -0.44
EPS and Forward PE are based on non-GAAP adjusted numbers.